翔宇医疗2026年规划：股东减持、脑机接口新品与市场扩张

Core Insights - The company has several noteworthy events planned or announced for 2026, particularly in the field of rehabilitation medical devices and brain-computer interface technology [1] Management Changes - The company's controlling shareholder, Anyang Qixu Trade Consulting Service Center (Limited Partnership), plans to reduce its stake by up to 3% of the total share capital between February 4 and May 3, 2026 [2] Product Development Progress - The company plans to launch dozens of new products, including brain-computer interfaces, in 2026, aiming to enhance its rehabilitation medical device portfolio and upgrade the brain-computer interface technology to a multimodal and multiparadigm system [3] Company Performance Goals - The company aims to expand its product coverage to over 1,000 top-tier hospitals by 2026, having already entered more than 500 such hospitals [4] Business Progress - Brain-computer interface-related products are expected to significantly boost performance in 2026, with clinical use and collaborative projects already underway in over 150 large hospitals [5] Project Advancement - The company is actively pursuing investment and acquisition opportunities to integrate industry resources, with financing activities proceeding in an orderly manner. Additionally, the brain-computer interface rehabilitation equipment technology innovation center, led by the company, was approved as a provincial platform in January 2026, which may continue to drive technological research and development [6]